CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation. [electronic resource]
Producer: 20150709Description: 152-60 p. digitalISSN:- 1872-8332
- Animals
- Apoptosis -- drug effects
- Autoantigens -- genetics
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Line, Tumor
- Cell Survival -- drug effects
- Disease Models, Animal
- ErbB Receptors -- genetics
- Erlotinib Hydrochloride
- Gene Expression Regulation, Neoplastic -- drug effects
- Heterografts
- Humans
- Intracellular Signaling Peptides and Proteins
- Lung Neoplasms -- drug therapy
- Membrane Proteins -- genetics
- Mice
- Protein Kinase Inhibitors -- pharmacology
- Protein Phosphatase 2 -- metabolism
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- Quinazolines -- pharmacology
- Signal Transduction -- drug effects
- Transcription, Genetic
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.